Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1

Molecular and Cellular Biology

Volumn 22, Issue 22, 2002, Pages 7929-7941

  Ayroldi, Emira ^a   Zollo, Ornella ^a   Macchiarulo, Antonio ^a   Di Marco, Barbara ^a   Marchetti, Cristina ^a   Riccardi, Carlo ^a  

^a Department of Clinical Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FAS LIGAND; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; LEUCINE ZIPPER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; PROTEIN FOS; RAF PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CERCOPITHECIDAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; DEXAMETHASONE; DNA-BINDING PROTEINS; GENES, FOS; GENES, JUN; GLUCOCORTICOIDS; INTERLEUKIN-2; LEUCINE ZIPPERS; LYMPHOCYTE ACTIVATION; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-RAF; SEQUENCE ALIGNMENT; T-LYMPHOCYTES; THYMUS GLAND; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

ANIMALIA; CERCOPITHECIDAE; MURINAE;

EID: 0036840376     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.22.7929-7941.2002     Document Type: Article

References (63)

1. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
2. Ayroldi, E., G. Migliorati, S. Bruscoli, C. Marchetti, O. Zollo, L. Cannarile, F. D'Adamio, and C. Riccardi. 2001. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB. Blood 98:743-753.
3. Ayroldi, E., O. Zollo, L. Cannarile, F. D'Adamio, U. Grohmann, D. V. Delfino, and C. Riccardi. 1998. Interleukin-6 (IL-6) prevents activationinduced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death. Blood 92:4212-4219.
4. Barnes, P. J., and I. Adcock. 1993. Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol. Sci. 14:436-441.
5. Beato, M. 1991. Transcriptional control by nuclear receptors. FASEB J. 5:2044-2051.
6. Boise, L. H., B. Petryniak, X. Mao, C. H. June, C. Y. Wang, T. Lindsten, R. Bravo, K. Kovary, J. M. Leiden, and C. B. Thompson. 1993. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13:1911-1919.
7. Chong, H., J. Lee, and K. L. Guan. 2001. Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J. 14:3716-3727.
8. Cissel, D. S., and M. A. Beaven. 2000. Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J. Biol. Chem. 275:7066-7070.
9. Coffer, P., M. De Jonge, A. Mettouchi, B. Binetruy, J. Ghysdael, and W. Kruijer. 1994. JunB promoter regulation: Ras-mediated transactivation by c-ets-1 and c-ets-2. Oncogene 9:911-921.
10. Cupps, T. R., and A. S. Fauci. 1982. Corticosteroid-mediated immunoregulation in man. Immunol. Rev. 165:133-155.
11. D'Adamio, F., O. Zollo, R. Moraca, E. Ayroldi, S. Bruscoli, A. Bartoli, L. Cannarile, G. Migliorati, and C. Riccardi. 1997. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7:803-812.
12. de Rooij, J., and J. L. Bos. 1997. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14:623-625.
13. Dhillon, A. S., S. Meikle, Z. Yazici, M. Eulitz, and W. Kolch. 2002. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21:64-71.
14. Diamond, M. I., J. N. Minner, S. K. Yoshinaga, and K. R. Yamamoto. 1990. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272.
15. ras upon T-cell activation. Nature 346:719-723.
16. Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagase, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
17. Fischer, D., and D. Eisenberg. 1996. Protein fold recognition using sequencederived predictions. Protein Sci. 5:947-955.
18. Franklin, R. A., A. Tordai, H. Patel, A. M. Gardner, G. L. Johnson, and E. W. Gelfand. 1994. Ligation of the T-cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J. Clin. Investig. 93:2134-2140.
19. Gabb, H. A., R. M. Jackson, and M. J. Sternberg. 1997. Modelling protein docking using shape complementarity, electrostatics and biochemical information. J. Mol. Biol. 272:106-120.
20. Garrity, P. A., D. Chen, E. V. Rothenberg, and B. J. Wold. 1994. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell. Biol. 14:2159-2169.
21. Gibrat, J. F., J. Garnier, and B. Robson. 1987. Further developments of protein secondary structure prediction using information theory: New parameters and consideration of residue pairs. J. Mol. Biol. 198: 425-443.
22. Hoffman, G. S. 1993. Immunosuppressive therapy for autoimmune diseases. Ann. Allergy 70:263-274.
23. Huber, T., and A. E. Torda. 1998. Protein fold recognition without Boltzmann statistics or explicit physical basis. Protein Sci. 7:142-149.
24. Huber, T., and A. E. Torda. 1999. Protein sequence threading, the alignment problem, and a two-step strategy. J. Comput. Chem. 20:1455-1467.
25. Hughes, C. C., and J. S. Pober. 1996. Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. Convergence of costimulatory signals and differences from transformed T cells. J. Biol. Chem. 271:5369-5377.
26. Iwata, M., S. Hanaoka, and K. Sato. 1991. Rescue of thymocytes and T-cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T-cell receptor/CD3 complex: A possible in vitro model for positive selection of the T-cell repertoire. Eur. J. Immunol. 21:643-648.
27. Jacinto, E., G. Werlen, and M. Karin. 1998. Cooperation between Syk and Racl leads to synergistic JNK activation in T lymphocytes. Immunity 8:3141.
28. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7:333-342.
29. Jain, J., V. E. Valge-Archer, and A. Rao. 1992. Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol. 148:1240-1250.
30. Jamieson, C. A., and K. R. Yamamoto. 2000. Cross talk pathway for inhibition of gluccocorticoid-induced apoptosis by T-cell receptor signaling. Proc. Natl. Acad. Sci. USA 97:7319-7324.
31. Kabelitz, D., T. Pohl, and K. Pechhold. 1993. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14: 338-339.
32. Kang, S. M., B. Beverly, A. C. Tran, K. Brorson, R. H. Schwartz, and M. J. Lenardo. 1992. Transactivation by AP-1 is a molecular target of T-cell clonal anergy. Science 257:1134-1138.
33. Kassel, O., A. Sancono, J. Kratzschmar, B. Kreft, M. Stassen, and A. C. Cato. 2001. Glucococorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20:7108-7116.
34. Kelley, L. A., R. M. MacCallum, and M. J. Sternberg. 2000. Enhanced genome annotation using structural profiles in the program 3D-PSSM. J. Mol. Biol. 299:499-520.
35. Kester, H. A., C. Blanchetot, J. den Hertog, P. T. van der Saag, and B. van der Burg. 1999. Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J. Biol. Chem. 274: 27439-27447.
36. Kolch, W. 2000. Meaningful relationships: The regulation of the Ras/Raf/Mek/Erk pathway by protein interactions. Biochem. J. 351:289-305.
37. Kwak, L. W., and D. L. Longo. 1996. Lymphomas, p. 347-375. In H. M. Pinedo, D. L. Longo, and B. A. Chabner (ed.), Cancer Chemotherapy and Biological Response Modifiers. Elsevier Science, Amsterdam, The Netherlands.
38. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
39. Luo, Z. J., X. F. Zhang, U. Rapp, and J. Avruch. 1995. Identification of the 14.3.3 ζ domains important for self-association and Raf binding. J. Biol. Chem. 40:23681-23687.
40. Luthy, R., J. U. Bowie, and D. Eisenberg. 1992. Assessment of protein models with three-dimensional profiles. Nature 356:83-85.
41. Maggirvar, S. B., E. W. Harhaj, and S. C. Sun. 1997. Regulation of the interleukin-2 CD28 responsive element by NF-ATp and various NF-κB/Rel transcription factors. Mol. Cell. Biol. 17:2605-2614.
42. Mittellstadt, P. R., and J. D. Ashwell. 2001. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276:29603-29610.
43. Mondino, A., C. D. Whaley, D. R. DeSilva, W. Li, M. K. Jenkins, and D. L. Mueller. 1996. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157:2048-2057.
44. Moont, G., H. A. Gabb, and M. J. E. Sternberg. 1999. Use of pair potentials across protein interfaces in screening predicted docked complexes. Proteins 35:364-373.
45. Morris, A. L., M. W. MacArthur, E. G. Hutchinson, and J. M. Thornton. 1992. Stereochemical quality of protein structure coordinates. Proteins 12: 345-364.
46. Morrison, D. K., and R. E. Cutler. 1997. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9:174-179.
47. Nassar, N., G. Horn, C. Herrmann, A. Scherer, F. McCormick, and A. Wittinghofer. 1995. The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 375:554-560.
48. Raff, M. C. 1992. Social controls on cell survival and cell death. Nature 356:397-400.
49. Ramirez, F. 1998. Glucocorticoids induce a Th2 response in vitro. Dev. Immunol. 6:233-243.
50. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752-756.
51. Riccardi, C., G. Cifone, and G. Migliorati. 1999. Glucocorticoid hormoneinduced modulation of gene expression and regulation of T-cell death: Role of GITR and GILZ, two dexamethasone-induced genes. Cell Death Differ. 12:1155-1163.
52. Riccardi, C., O. Zollo, G. Nocentini, S. Bruscoli, A. Bartoli, F. D'Adamio L. Cannarile, D. Delfino, E. Ayroldi, and G. Migliorati. 2000. Glucocorticoid hormones in the regulation of the cell death. Therapie 55:165-169.
53. Rider, L. G., N. Hirasawa, F. Santini, and M. A. Beaven. 1996. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J. Immunol. 157:2374-2380.
54. Rincon, M. 2001. MAP-kinase signaling pathways in T-cell. Curr. Opin. Immunol. 13:339-345.
55. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
56. Schüle, R., P. Rangarajan, S. Kliewer, L. I. Ransone, J. Bolado, N. Yang, I. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
57. Schwartz, R. H. 1997. T-cell clonal anergy. Curr. Opin. Immunol. 9:351-357.
58. Seidel, G., K. Adermann, T. Schindler, A. Ejchart, R. Jaenicke, W. G. Forssmann, and P. Rosch. 1997. Solution structure of porcine delta sleep-inducing peptide immunoreactive peptide A homolog of the shortsighted gene product. J. Biol. Chem. 272:30918-30927.
59. Serfling, E., R. Barthelmas, I. Pleuffer, B. Schenk, S. Zarius, R. Swoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin-2 gene in T lymphocytes. EMBO J. 8:465-473.
60. Shimonkevitz, R., J. Kappler, P. Marrack, and H. Grey. 1983. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J. Exp. Med. 158:303-316.
61. Whitehurst, C. E., and T. D. Geppert. 1996. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 156:1020-1029.
62. Widen, C., J. Zilliacus, J. A. Gustafsson, and A. C. Wikstrom. 2000. Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways. J. Biol. Chem. 275:39296-39301.
63. Wlemik, P. H. 1996. Leukemia and myeloma, p. 347-375. In H. M. Pinedo, D. L. Longo, and B. A. Chabner (ed.), Cancer Chemotherapy and Biological Response Modifiers. Elsevier Science, Amsterdam, The Netherlands.